Checkpoint immunotherapy : good for cancer therapy, bad for rheumatic diseases
Clinical trials of biosimilars should become more similar
Is it time to revisit the role of ultrasound in rheumatoid arthritis management?
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome : A consensus and data-driven methodology involving three international patient cohorts
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders : 2015/2016 update
2016 updated EULAR evidence-based recommendations for the management of gout
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy
A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis : the HERA study
Allopurinol and the risk of atrial fibrillation in the elderly : a study using Medicare data
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis : results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs : results from the RA-BUILD study
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors : 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors : a collaborative study from the ARTIS and DANBIO registers
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis : a study exploring replication and the added value to ACPA and rheumatoid factor
How well do ACPA discriminate and predict RA in the general population : a study based on 12 590 population-representative Swedish twins
Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis : a discrete choice experiment among European rheumatologists
Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure
Does knee replacement surgery for osteoarthritis improve survival? The jury is still out
Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus
Long-term outcome in juvenile-onset mixed connective tissue disease : a nationwide Norwegian study
Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS) : an open-label, phase II study
Establishment of reference intervals for osteoarthritis-related soluble biomarkers : the FNIH/OARSI OA Biomarkers Consortium
Predictive validity of biochemical biomarkers in knee osteoarthritis : data from the FNIH OA Biomarkers Consortium
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611) : results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis : results from a randomised phase III trial (FUTURE 1)
High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis : results from the BRAGGSS cohort
Bone marrow lesions and synovitis on MRI associate with radiographic progression after 2 years in hand osteoarthritis
WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritis
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis
Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis
Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation
Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis : derivation and validation of a preliminarily revised EUSTAR activity index
Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes
A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus
Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
A family-based genome-wide association study reveals an association of spondyloarthritis with MAPK14
Erratum : Differences and similarities in rheumatology speciality training programmes across European countries
Renal dosing of allopurinol results in suboptimal gout care
Response : Renal dosing of allopurinol results in suboptimal gout care by T Neogi et al